Shanghai Fudan Forward S&T Co

Shanghai Fudan Forward S&T Co Interest Coverage

The Interest Coverage Ratio of Shanghai Fudan Forward S&T Co (600624.SS) as of Oct 29, 2026 is -8.18. In the previous year, Interest Coverage Ratio was -0.12 — a change of 6,874.03% (lower).

Interest Coverage

-8.18

YoY

6,874.03%

Last updated:

Interest Coverage Ratio of Shanghai Fudan Forward S&T Co is 2024 -8.18 . Interest Coverage Ratio of Shanghai Fudan Forward S&T Co was 2023 -0.12 . It decreases by 6,874.03% lower compared to the previous year.

The Shanghai Fudan Forward S&T Co Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
14.74 CNY
Jan 1, 2018
28.65 CNY
Jan 1, 2019
2.80 CNY
Jan 1, 2020
-1.07 CNY
Jan 1, 2021
-2.45 CNY
Jan 1, 2022
0.16 CNY
Jan 1, 2023
-0.12 CNY
Jan 1, 2024
-8.18 CNY
The Shanghai Fudan Forward S&T Co Interest Coverage history
YEARInterest CoverageYoY
-8.18+6,874.03%
-0.12-171.73%
0.16-106.69%
-2.45+127.63%
-1.07-138.38%
2.80-90.23%
28.65+94.35%
14.74-90.30%
152.01+747.90%
17.93+475.94%
3.11—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Shanghai Fudan Forward S&T Co Stock analysis

What does Shanghai Fudan Forward S&T Co do? Shanghai Fudan Forward S&T Co., Ltd. generates revenue through the research, development, production, and sale of pharmaceutical products, including digestive system drugs, nervous system drugs, antineoplastic drugs, circulatory drugs, and immune function medications. The company also provides financial insurance software products. Its domestic and overseas markets serve as key sales channels for these pharmaceuticals and software solutions. The firm's product portfolio targets healthcare providers, hospitals, and pharmacies within the pharmaceutical sector. The company's pharmaceutical segment focuses on specialized drug categories such as digestive system and nervous system treatments, alongside antineoplastic and circulatory drugs. Financial insurance software products complement its core pharmaceutical business, offering additional revenue streams. Domestic markets account for a significant portion of sales, while overseas markets expand its global reach. Shanghai Fudan Forward S&T Co., Ltd. leverages its 1,426 full-time employees to support both pharmaceutical and software operations. The firm's product offerings cater to healthcare institutions requiring specialized medications and digital solutions for insurance management. This dual focus allows the company to serve multiple segments within the healthcare and financial technology industries. Shanghai Fudan Forward S&T Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shanghai Fudan Forward S&T Co stock

Interest Coverage Ratio of Shanghai Fudan Forward S&T Co is -8.18 in 2024.

Interest Coverage Ratio of Shanghai Fudan Forward S&T Co changed from -0.12 to -8.18, representing a 6,874.03% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Shanghai Fudan Forward S&T Co since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Shanghai Fudan Forward S&T Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Shanghai Fudan Forward S&T Co

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Shanghai Fudan Forward S&T Co